SCHEMBL565131

SCHEMBL565131

CCN(Cc1ccccc1)CC(C)C(=O)N(Cc1cc(Cl)c2c(c1)OCCCO2)CC(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PROKR2 Q8NFJ6 5/20 0.54
POLB P06746 2/20 0.36
CHRM5 P08912 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
ALDH1A1 P00352 4/20 0.35
MAPK8 P45983 1/20 0.35
TSHR P16473 4/20 0.35
GAA P10253 2/20 0.35
HPGD P15428 2/20 0.35
MAPT P10636 1/20 0.35
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC9 Q9UKV0 1/20 0.34
HDAC5 Q9UQL6 1/20 0.34
LMNA P02545 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL565624 0.89 PROKR2 (0.56) PROKR2POLBNPC1RAB9AALDH1A1
SCHEMBL565297 0.87 PROKR2 (0.52) PROKR2POLBCHRM5NPC1RAB9A
SCHEMBL564264 0.87 PROKR2 (0.52) PROKR2POLBCHRM5NPC1RAB9A
SCHEMBL15693909 0.84 PROKR2 (0.69) PROKR2NPC1RAB9AALDH1A1MAPK8
SCHEMBL565524 0.84 PROKR2 (0.69) PROKR2NPC1RAB9AALDH1A1MAPK8
SCHEMBL565109 0.84 PROKR2 (0.69) PROKR2NPC1RAB9AALDH1A1MAPK8
SCHEMBL565158 0.82 PROKR2 (0.57) PROKR2NPC1RAB9AMAPK8HDAC3
SCHEMBL20915071 0.82 PROKR2 (0.57) PROKR2NPC1RAB9AMAPK8HDAC3
SCHEMBL10119874 0.82 PROKR2 (0.56) PROKR2NPC1RAB9AALDH1A1MAPK8
SCHEMBL565858 0.82 PROKR2 (0.56) PROKR2NPC1RAB9AALDH1A1MAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof PROKR2, PROKR1, GIPR PROKR2 1/4885POLB 3608/4885CHRM5 1010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.